<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04782596</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-Septum</org_study_id>
    <nct_id>NCT04782596</nct_id>
  </id_info>
  <brief_title>Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions</brief_title>
  <official_title>Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to compare the effect of different extent of resection of the&#xD;
      posterior part of the septum on the postoperative nasal functions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The nasal cavity is used to heat, humidify and purify the air before entering other parts of&#xD;
      the respiratory system. Other functions of the nose include in particular olfactory, immune,&#xD;
      reflex or sexual functions.&#xD;
&#xD;
      Proper airflow through the nasal cavity is essential for all nasal functions; anatomical or&#xD;
      flow changes can significantly affect nasal functions.&#xD;
&#xD;
      Endoscopic transnasal surgical approaches are modern, mini-invasive methods, enabling&#xD;
      solution of pathologies in the area of the cranial base, through the nasal cavity. The&#xD;
      advantage of this technique is absence of external incisions and scars and significantly&#xD;
      better cosmetic effect, these methods also offer very good clarity and illumination of the&#xD;
      operating field. Main disadvantage is risk of affecting functions of the nose.&#xD;
&#xD;
      To create a transnasal approach to skull base, it is necessary to perform lateralization of&#xD;
      middle turbinates, resection of anterior wall of sphenoidal sinus and resection of posterior&#xD;
      part of the nasal septum. These interventions are necessary for a good overview and&#xD;
      manipulation in the operated area; however, they can lead to postoperative changes in the&#xD;
      physiological functions of the nasal cavity, especially loss of smell, taste, altered airflow&#xD;
      through the nasal cavity, mucociliary transport disorders, nasal obstruction, crusting or&#xD;
      drying mucous membrane. All these adverse changes significantly affect patient's quality of&#xD;
      life.&#xD;
&#xD;
      Larger extent of septal resection allows the surgeon to have a better overview and&#xD;
      manoeuvrability in the operated area, which allows sufficient radicality and allows the&#xD;
      solution of possible complications. On the other hand, greater resection also means greater&#xD;
      interference with the anatomy of the nasal cavity and possible influence on nasal functions.&#xD;
&#xD;
      The aim of the project is to compare the effect of different extent of resection of the&#xD;
      posterior part of the septum on the postoperative nasal functions.&#xD;
&#xD;
      Study design:&#xD;
&#xD;
        -  all operations will be performed by the same operations team&#xD;
&#xD;
        -  prior to surgery, patients will be randomly tossed into two groups according to the&#xD;
           extent of resection of the posterior edge of the septum as part of the transsphenoidal&#xD;
           approach during cranial base surgery&#xD;
&#xD;
        -  group A - Patients will be resected with a posterior 1 cm nasal septum as part of a&#xD;
           transsphenoidal approach.&#xD;
&#xD;
        -  group B - Patients will be resected with a 2 cm posterior nasal septum as part of a&#xD;
           transsphenoidal approach&#xD;
&#xD;
        -  if the selected extent of resection is not sufficient during surgery for group A, it&#xD;
           will be extended so that the lesion can be safely removed, and patient will be removed&#xD;
           from study&#xD;
&#xD;
      Operational procedure:&#xD;
&#xD;
        1. Anemization of the nasal mucosa using strips with diluted adrenaline 1: 1000.&#xD;
&#xD;
        2. Endoscopy of the nasal cavity and identification of important anatomical structures.&#xD;
&#xD;
        3. Lateralization of the middle and upper turbinates, identification of the anterior wall&#xD;
           of the sphenoidal sinus and its natural ostium.&#xD;
&#xD;
        4. Apply suction with a marked distance of 1 and 2 cm to the septum and mark the extent of&#xD;
           laser resection on the septal mucosa.&#xD;
&#xD;
           The suction is applied paraseptally to the anterior wall of the sphenoidal sinus at the&#xD;
           height of the natural ostium (1.5 cm above the upper edge of the choana), the caudal&#xD;
           border of the resection is the height of the upper edge of the choana, the cranial&#xD;
           border is the ceiling of the sphenoid.&#xD;
&#xD;
        5. Resection of the septum in the given range.&#xD;
&#xD;
        6. Resection of the anterior wall of the sphenoidal sinus, resection of the intersphenoidal&#xD;
           septum.&#xD;
&#xD;
        7. Rest of the operation is identical in both groups of patients (tumour resection,&#xD;
           revision of the nasal cavity, nasal tamponade).&#xD;
&#xD;
             -  At preoperative examination and 1 month after surgery, patients will have:&#xD;
&#xD;
             -  endoscopy of the nasal cavity with Lund-Kennedy scoring system (evaluation of&#xD;
                oedema, secretion, crust)&#xD;
&#xD;
             -  olfactory examination - test of identification and discrimination with perfumed&#xD;
                markers&#xD;
&#xD;
             -  SNOT 22 questionnaire&#xD;
&#xD;
             -  RhinoVAS questionnaire&#xD;
&#xD;
             -  Nose score&#xD;
&#xD;
      Statistical evaluation:&#xD;
&#xD;
        -  comparison of nasal functions after cranial base surgery in patients with a range of&#xD;
           resection of the posterior edge of the septum 1 cm and 2 cm&#xD;
&#xD;
        -  comparison of olfactory before and after surgery in both groups of patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study subjects will be randomised into two parallel groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking will be used in the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in nasal endoscopy</measure>
    <time_frame>2 months</time_frame>
    <description>Nasal endoscopy will be performed to assess postoperative changes in nasal function (using Lund-Kennedy scoring system)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in sino-nasal outcome test</measure>
    <time_frame>2 months</time_frame>
    <description>Sino-nasal outcome test will be used to assess postoperative changes in nasal function (using standardised SNOT 22 questionnaire)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in RhinoVAS questionnaire</measure>
    <time_frame>2 months</time_frame>
    <description>RhinoVAS questionnaire will be used to assess postoperative changes in nasal function (using standardised RhinoVAS questionnaire)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the quality of life</measure>
    <time_frame>2 months</time_frame>
    <description>Changes in the quality of life of study subjects will be assessed using standard quality of life measurement tools (e.g. Health-Related Quality of Life - HRQL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pituitary Adenoma</condition>
  <arm_group>
    <arm_group_label>One-centimeter resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the study subjects enrolled into this study arm, one-centimetre resection will be used for the transnasal endoscopic pituitary surgery procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two-centimeter resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the study subjects enrolled into this study arm, two-centimetre resection will be used for the transnasal endoscopic pituitary surgery procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterium nasal septum resection</intervention_name>
    <description>Posterium nasal septum resection is required to ensure approach during transnasal endoscopic pituitary surgery in patients with pituitary adenoma.</description>
    <arm_group_label>One-centimeter resection</arm_group_label>
    <arm_group_label>Two-centimeter resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age over 18 years&#xD;
&#xD;
          -  patients with functional pituitary adenoma indicating endoscopic transnasal&#xD;
             extirpation of the pituitary adenoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients after surgery of the nasal cavity or base of the skull&#xD;
&#xD;
          -  patients with nasal disease and PND&#xD;
&#xD;
          -  patients with olfactory disorders before surgery&#xD;
&#xD;
          -  patients with nasal septal deviation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jakub Lubojacký, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiří Hynčica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiří Hynčica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact>
    <investigator>
      <last_name>Jakub Lubojacký, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petr Matoušek, MD,Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Radim Lipina, Assoc.Prof.,MD,Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marek Plášek, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michaela Mesárová, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Kántor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Alobid I, Enseñat J, Mariño-Sánchez F, Rioja E, de Notaris M, Mullol J, Bernal-Sprekelsen M. Expanded endonasal approach using vascularized septal flap reconstruction for skull base tumors has a negative impact on sinonasal symptoms and quality of life. Am J Rhinol Allergy. 2013 Sep-Oct;27(5):426-31. doi: 10.2500/ajra.2013.27.3932.</citation>
    <PMID>24119608</PMID>
  </reference>
  <reference>
    <citation>Rioja E, Bernal-Sprekelsen M, Enriquez K, Enseñat J, Valero R, de Notaris M, Mullol J, Alobid I. Long-term outcomes of endoscopic endonasal approach for skull base surgery: a prospective study. Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1809-17. doi: 10.1007/s00405-015-3853-9. Epub 2015 Dec 19.</citation>
    <PMID>26688432</PMID>
  </reference>
  <reference>
    <citation>Bedrosian JC, McCoul ED, Raithatha R, Akselrod OA, Anand VK, Schwartz TH. A prospective study of postoperative symptoms in sinonasal quality-of-life following endoscopic skull-base surgery: dissociations based on specific symptoms. Int Forum Allergy Rhinol. 2013 Aug;3(8):664-9. doi: 10.1002/alr.21161. Epub 2013 Mar 20.</citation>
    <PMID>23520019</PMID>
  </reference>
  <reference>
    <citation>Bhenswala PN, Schlosser RJ, Nguyen SA, Munawar S, Rowan NR. Sinonasal quality-of-life outcomes after endoscopic endonasal skull base surgery. Int Forum Allergy Rhinol. 2019 Oct;9(10):1105-1118. doi: 10.1002/alr.22398. Epub 2019 Jul 29. Review.</citation>
    <PMID>31356005</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pituitary adenoma</keyword>
  <keyword>nasal functions</keyword>
  <keyword>posterior nasal septum resection</keyword>
  <keyword>transnasal approach</keyword>
  <keyword>endoscopic pituitary surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
    <mesh_term>Pituitary Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers. Individual participant data may be provided upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

